Tekmira Conference Call and Webcast Advisory: Corporate Update and First
Quarter Financial Results
VANCOUVER, British Columbia, May 9, 2013 (GLOBE NEWSWIRE) -- Tekmira
Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of
RNA interference (RNAi) therapeutics, announced that it will hold a conference
call and webcast on Tuesday, May 14, 2013 at 1:00 pm Pacific Time (4:00 pm
Eastern Time) to provide a corporate update and report financial results for
the first quarter ended March 31, 2013.
Conference Call and Webcast Information
A live webcast of the call can be accessed through the Investor section of
Tekmira's website at www.tekmirapharm.com. Or, alternatively, to access the
conference call, please dial 914-495-8556 or 1-866-393-1607.
An archived webcast will be available on the Tekmira website approximately two
hours after the event. Alternatively, you may access a replay of the
conference call by calling 404-537-3406 or 1-855-859-2056 and referencing
conference ID 69658053.
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on
advancing novel RNAi therapeutics and providing its leading lipid nanoparticle
delivery technology to pharmaceutical partners. Tekmira has been working in
the field of nucleic acid delivery for over a decade and has broad
intellectual property covering LNPs. Further information about Tekmira can be
found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.
Director, Investor Relations
Longview Communications Inc.
Tekmira Pharmaceuticals Logo
Press spacebar to pause and continue. Press esc to stop.